3 Comments


  1. Shelley Wood.
    HeartWire. October 19, 2011.

    Las Vegas, NV – Thirty-day and three-month results from an eagerly-awaited first trial to test a drug-eluting stent for the treatment of erectile dysfunction suggest that this novel use for a DES is safe, and associated with significant improvement in erectile function and satisfaction. But the trial also encountered logistical problems related to the uncharted complex terrain of the pelvic vasculature, meaning that the next trial in this arena is going to take a step back.

  2. It seems that Department of Urology will be a branch of the Department of Cardiology. Two become one. 🙂

Leave a Reply

Your email address will not be published. Required fields are marked *